Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (3) , 338-343
- https://doi.org/10.1016/0959-8049(94)90253-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of folate diastereoisomers on the binding of 5-fluoro-2'-deoxyuridine-5'- monophosphate to thymidylate synthaseBiochemical Pharmacology, 1993
- Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinomaEuropean Journal Of Cancer, 1992
- Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acidEuropean Journal Of Cancer, 1992
- Thymidylate synthase from untreated human colorectal cancer and colonic mucosa: Enzyme activity and inhibition by 5-fluoro-2′-deoxyuridine-5′-monophosphateEuropean Journal of Cancer and Clinical Oncology, 1991
- Comparative effect of 6S, 6R and 6RS Leucovorin on methotrexate rescue and on modulation of 5-fluorouracilBritish Journal of Cancer, 1991
- Enhancement of the antitumor effects of 5-fluorouracil by folinic acidPharmacology & Therapeutics, 1990
- Clinical Pharmacokinetics of High-Dose Leucovorin Calcium After Intravenous and Oral AdministrationJNCI Journal of the National Cancer Institute, 1990
- The Natural and Unnatural Diastereomers of Leucovorin: Aspects of their Cellular PharmacologyPublished by Springer Nature ,1988
- Reporting results of cancer treatmentCancer, 1981
- Stereospecificity at carbon 6 of formyltetrahydrofolate as a competitive inhibitor of transport and cytotoxicity of methotrexate in vitroBiochemical Pharmacology, 1979